Pharma giant Novartis is developing drugs that could prevent cancer before patients get it. One big question: how will we pay for them?
Read more
$225 billion drug giant Novartis is taking a fresh approach to cancer treatment, and it could help prepare it for a ‘doomsday scenario’
Posted in biotech/medical, existential risks